Astrana Health (NASDAQ:ASTH) Shares Gap Up – Should You Buy?

Astrana Health, Inc. (NASDAQ:ASTH) shares gapped up prior to trading on Tuesday . The stock had previously closed at $29.29, but opened at $32.00. Astrana Health shares last traded at $32.09, with a volume of 35,865 shares changing hands.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Bank of America reduced their price objective on Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research report on Tuesday, March 4th. Macquarie upgraded shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Truist Financial cut their price objective on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th. Robert W. Baird decreased their target price on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Finally, Stifel Nicolaus cut their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Astrana Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $53.29.

Astrana Health Stock Performance

The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm has a market cap of $1.58 billion, a P/E ratio of 24.47, a PEG ratio of 1.37 and a beta of 1.04. The stock’s 50 day moving average is $33.00 and its two-hundred day moving average is $40.83.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). The company had revenue of $665.21 million for the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. As a group, equities analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

Several institutional investors have recently added to or reduced their stakes in the company. State Street Corp acquired a new stake in shares of Astrana Health during the third quarter worth approximately $91,966,000. Geode Capital Management LLC bought a new stake in Astrana Health during the 3rd quarter worth approximately $58,995,000. Principal Financial Group Inc. acquired a new stake in Astrana Health during the 3rd quarter valued at $13,383,000. 325 Capital LLC raised its position in Astrana Health by 30.3% in the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company’s stock valued at $27,964,000 after purchasing an additional 206,009 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its stake in Astrana Health by 217.6% in the fourth quarter. Renaissance Technologies LLC now owns 217,900 shares of the company’s stock worth $6,870,000 after purchasing an additional 149,300 shares in the last quarter. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.